Simonian PL, Roark CL, Wehrmann F, Lanham AK, Born WK, O’Brien RL and Fontenot AP. IL-17A expressing T cells are essential for bacterial clearance in a murine model of hypersensitivity pneumonitis. J Immunol. 2009; 182:6540-6549.
Simonian PL, Roark CL, Wehrmann F, Lanham AK, Diaz del Valle F, Born WK, O’Brien RL and Fontenot AP. Th17 polarized immune response in a murine model of hypersensitivity pneumonitis and pulmonary fibrosis. J Immunol. 2009; 182:657-665.
Simonian PL, Roark CL, Born WK, O’Brien RL and Fontenot AP. γδ T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis. Transl Res. 2009; 154(5):222-7.
Roark CL, Simonian PL, Fontenot AP, Born WK and O’Brien RL. γδ T cells: an important source of IL-17. Curr Opin Immunol. 2008; 20(3):353-357.
Simonian PL, Roark CL, Diaz del Valle F, Palmer BE, Douglas IS, Ikuta K, Born WK, O’Brien RL and Fontenot AP. Regulatory role of γδ T cells in the recruitment of CD4+ and CD8+ to lung and subsequent pulmonary fibrosis. J Immunol. 2006; 177:4436-4443.
Sullivan AK, Simonian PL, Falta MT, Cosgrove GP, Brown KK, Kotzin BL, Voelkel NF and Fontenot AP. Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 2005; 172:590-596.
Simonian PL, Grillot DA and Nunez G. Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death. Blood. 1997; 90:120-1216.
Simonian PL, Grillot DA, Merino R and Nunez G. Bax can antagonize Bcl-XL during chemotherapy-induced cell death independently of its heterodimerization with Bcl-XL. J Biol Chem. 1996; 271:22764-22772.
Simonian PL, Grillot DA, Andrews DW, Leber B and Nunez G. Bax homodimerization is not required for Bax to accelerate chemotherapy-induced cell death. J Biol Chem. 1996; 271:32073-32077.
Simonian PL, Grillot DA and Nunez G. Bak can accelerate chemotherapy-induced cell death independently of its heterodimerization with Bcl-XL and Bcl-2. Oncogene. 1997; 15:1871-1875.
Merino R, Grillot DA, Simonian PL, Muthukumar S, Fanslow WC, Bondada S and Nunez G. Modulation of anti-IgM-induced B cell apoptosis by Bcl-XL and CD40 in WEHI-231 cells: Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. J Immunol. 1995; 155:3830-3838.
Foreman KE, Wrone-Smith T, Boise LH, Thompson CB, Polverini PJ, Simonian PL, Nunez G and Nickloff BJ. Kaposi’s sarcoma tumor cells preferentially express Bcl-XL. Am J Path. 1996; 149:795-803.
Nunez G, Merino R, Simonian PL and Grillot DA. Regulation of lymphoid apoptosis by Bcl-2 and Bcl-XL. Adv Exp Med & Biol. 1996; 406:75-82.
Bojes HK, Datta K, Xu J, Chin A, Simonian P, Nunez G and Kehrer JP. Bcl-XL overexpression attenuates glutathione depletion in FL5.12 cells following interleukin-3 withdrawal. Bichem J. 1997; 325:315-319.
Mitra RS, Wrone-Smith T, Simonian P, Foreman KE, Nunez G and Nickloff BJ. Apoptosis in keratinocytes is not dependent on induction of differentiation. Lab Invest. 1997; 76:99-107.
Raghu G, Pierre-Jerome M, Dordal MS, Simonian P, Bauer KD and Winter JN. P-glycoprotein and alterations in the glutathione/glutathione peroxidase cycle underlie doxorubicin in HL-60-R, a subclone of the HL-60 human leukemia cell line. Int J Cancer. 1993; 53:804-811.
George A, Sabsay B, Simonian P and Veis A. Characterization of a novel dentin matrix acidic phosphoprotein. Implications of induction of biomineralization. J Biol Chem. 1993; 268:12624-12630.